Related Experiment Video
Updated: Jun 11, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
Published on: November 29, 2016
Early response to ErbB2 over-expression in polarized Caco-2 cells involves partial segregation from ErbB3 by
Amber B Pfister1, Robert C Wood, Pedro J I Salas
1Department of Pharmaceutical Sciences, Bill Gatton College of Pharmacy, East Tennessee State University, Johnson City, Tennessee 37614, USA.
Abstract:
In several human cancers, ErbB2 over-expression facilitates the formation of constitutively active homodimers resistant to internalization which results in progressive signal amplification from the receptor, conducive to cell survival, proliferation, or metastasis. Here we report on studies of the influence of ErbB2 over-expression on localization and signaling in polarized Caco-2 and MDCK cells, two established models to study molecular trafficking. In these cells, ErbB2 is not over-expressed and shares basolateral localization with ErbB3. Over-expression of ErbB2 by transient transfection resulted in partial separation of the receptors by relocalization of ErbB2, but not ErbB3, to the apical surface, as shown by biotinylation of the apical or basolateral surfaces. These results were confirmed by immunofluorescence and confocal microscopy. Polarity controls indicated that the relocalization of ErbB2 is not the result of depolarization of the cells. Biotinylation and confocal microscopy also showed that apical, but not basolateral ErbB2 is activated at tyrosine 1139. This phosphotyrosine binds adaptor protein Grb2, as confirmed by immunoprecipitation. However, we found that it does not initiate the canonical Grb2-Ras-Raf-Erk pathway. Instead, our data supports the activation of a survival pathway via Bcl-2. The effects of ErbB2 over-expression were abrogated by the humanized anti-ErbB2 monoclonal antibody Herceptin added only from the apical side. The ability of apical ErbB2 to initiate an altered downstream cascade suggests that subcellular localization of the receptor plays an important role in regulating ErbB2 signaling in polarized epithelia.
Insights
Over-expressing ErbB2 (Epidermal Growth Factor Receptor 2) in polarized cells relocates it to the apical surface, activating a survival pathway via Bcl-2, not the canonical Erk pathway. This apical ErbB2 signaling is blocked by Herceptin.
Area of Science:
- Molecular Cell Biology
- Cancer Research
- Epithelial Biology
Background:
- ErbB2 (Epidermal Growth Factor Receptor 2) over-expression in cancers drives signaling, promoting cell survival, proliferation, and metastasis.
- Polarized epithelial cells (Caco-2, MDCK) are models for studying molecular trafficking and receptor localization.
- Normally, ErbB2 and ErbB3 share basolateral localization in these cells without over-expression.
Purpose of the Study:
- To investigate the impact of ErbB2 over-expression on its localization and signaling pathways in polarized Caco-2 and MDCK cells.
- To determine if ErbB2 relocalization affects downstream signaling cascades.
- To assess the role of subcellular localization in regulating ErbB2 activity in polarized epithelia.
Main Methods:
- Transient transfection to over-express ErbB2 in Caco-2 and MDCK cells.
- Biotinylation of apical and basolateral surfaces to track receptor localization.
- Immunofluorescence and confocal microscopy for visualizing receptor distribution.
- Immunoprecipitation to confirm protein-protein interactions (phosphotyrosine binding Grb2).
- Treatment with anti-ErbB2 monoclonal antibody Herceptin.
Main Results:
- ErbB2 over-expression caused ErbB2, but not ErbB3, to relocalize to the apical surface, without disrupting cell polarity.
- Apical ErbB2, but not basolateral ErbB2, was activated at tyrosine 1139, binding to Grb2.
- This interaction initiated a survival pathway via Bcl-2, bypassing the canonical Grb2-Ras-Raf-Erk pathway.
- Herceptin, applied apically, abrogated the effects of over-expressed ErbB2.
Conclusions:
- Subcellular localization of ErbB2 is critical for regulating its signaling in polarized epithelia.
- Apical ErbB2 over-expression activates a distinct downstream cascade involving Bcl-2, promoting cell survival.
- Targeting apical ErbB2 with antibodies like Herceptin can inhibit its oncogenic signaling.
Related Concept Videos
Cell Polarization by Rho Proteins
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
